Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheuma...

全面介紹

書目詳細資料

Principais autores:	Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, G V Lukina, E L Nasonov
格式:	Artigo
語言:	Russo
出版:	IMA PRESS LLC 2012-08-01
叢編:	Научно-практическая ревматология
主題:	das 28 sdai cdai rheumatoid arthritis tocilizumab rituximab remission
在線閱讀:	https://rsp.mediar-press.net/rsp/article/view/1032
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!